Epigenetic gene silencing in cancer: the DNA hypermethylome - PubMed (original) (raw)
Review
. 2007 Apr 15:16 Spec No 1:R50-9.
doi: 10.1093/hmg/ddm018.
Affiliations
- PMID: 17613547
- DOI: 10.1093/hmg/ddm018
Review
Epigenetic gene silencing in cancer: the DNA hypermethylome
Manel Esteller. Hum Mol Genet. 2007.
Abstract
Epigenetic gene inactivation in transformed cells involves many 'belts of silencing'. One of the best-known lesions of the malignant cell is the transcriptional repression of tumor-suppressor genes by promoter CpG island hypermethylation. We are in the process of completing the molecular dissection of the entire epigenetic machinery involved in methylation-associated silencing, such as DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylases, histone methyltransferases, histone demethylases and Polycomb proteins. The first indications are also starting to emerge about how the combination of cellular selection and targeted pathways leads to abnormal DNA methylation. One thing is certain already, promoter CpG island hypermethylation of tumor-suppressor genes is a common hallmark of all human cancers. It affects all cellular pathways with a tumor-type specific profile, and in addition to classical tumor-suppressor and DNA repair genes, it includes genes involved in premature aging and microRNAs with growth inhibitory functions. The importance of hypermethylation events is already in evidence at the bedside of cancer patients in the form of cancer detection markers and chemotherapy predictors, and in the approval of epigenetic drugs for the treatment of hematological malignancies. In the very near future, the synergy of candidate gene approaches and large-scale epigenomic technologies, such as methyl-DIP, will yield the complete DNA hypermethylome of cancer cells.
Similar articles
- Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.
Agrelo R, Cheng WH, Setien F, Ropero S, Espada J, Fraga MF, Herranz M, Paz MF, Sanchez-Cespedes M, Artiga MJ, Guerrero D, Castells A, von Kobbe C, Bohr VA, Esteller M. Agrelo R, et al. Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8822-7. doi: 10.1073/pnas.0600645103. Epub 2006 May 24. Proc Natl Acad Sci U S A. 2006. PMID: 16723399 Free PMC article. - Mutator pathways unleashed by epigenetic silencing in human cancer.
Jacinto FV, Esteller M. Jacinto FV, et al. Mutagenesis. 2007 Jul;22(4):247-53. doi: 10.1093/mutage/gem009. Epub 2007 Apr 4. Mutagenesis. 2007. PMID: 17412712 Review. - CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M. Esteller M. Oncogene. 2002 Aug 12;21(35):5427-40. doi: 10.1038/sj.onc.1205600. Oncogene. 2002. PMID: 12154405 Review. - Gene methylation in gastric cancer.
Qu Y, Dang S, Hou P. Qu Y, et al. Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Clin Chim Acta. 2013. PMID: 23669186 Review. - Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y. Yuan J, et al. Cancer Res. 2003 Jul 15;63(14):4174-80. Cancer Res. 2003. PMID: 12874023
Cited by
- Recognition of 5-methyl-CG and CG base pairs in duplex DNA with high stability using antiparallel-type triplex-forming oligonucleotides with 2-guanidinoethyl-2'-deoxynebularine.
Notomi R, Sasaki S, Taniguchi Y. Notomi R, et al. Nucleic Acids Res. 2022 Nov 28;50(21):12071-12081. doi: 10.1093/nar/gkac1110. Nucleic Acids Res. 2022. PMID: 36454012 Free PMC article. - Beyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic Events.
Martínez R. Martínez R. J Signal Transduct. 2012;2012:519807. doi: 10.1155/2012/519807. Epub 2012 Jun 18. J Signal Transduct. 2012. PMID: 22778947 Free PMC article. - Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.
Lee JH, Khor TO, Shu L, Su ZY, Fuentes F, Kong AN. Lee JH, et al. Pharmacol Ther. 2013 Feb;137(2):153-71. doi: 10.1016/j.pharmthera.2012.09.008. Epub 2012 Oct 3. Pharmacol Ther. 2013. PMID: 23041058 Free PMC article. Review. - A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer.
Stubendorff B, Wilhelm K, Posselt K, Catto J, Hartmann A, Bertz S, Füssel S, Novotny V, Toma M, Gajda M, Lehmann J, Wunderlich H, Grimm MO, Stöckle M, Junker K. Stubendorff B, et al. J Cancer Res Clin Oncol. 2019 Apr;145(4):811-820. doi: 10.1007/s00432-018-02829-4. Epub 2019 Jan 2. J Cancer Res Clin Oncol. 2019. PMID: 30603903 - Heterochromatin protein 1alpha: a hallmark of cell proliferation relevant to clinical oncology.
De Koning L, Savignoni A, Boumendil C, Rehman H, Asselain B, Sastre-Garau X, Almouzni G. De Koning L, et al. EMBO Mol Med. 2009 Jun;1(3):178-91. doi: 10.1002/emmm.200900022. EMBO Mol Med. 2009. PMID: 20049717 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources